DEGRO practical guidelines: Radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer

Strahlentherapie und Onkologie

Volumn 189, Issue 10, 2013, Pages 825-833

  Sedlmayer, F ^a   Sautter Bihl, M L ^b   Budach, W ^c   Dunst, J ^d   Fastner, G ^a   Feyer, P ^e   Fietkau, R ^f   Haase, W ^g   Harms, W ^h   Souchon, R ⁱ   Wenz, F ^j   Sauer, R ^f  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^g formerly St Vincentius Kliniken   (Germany)

^h St Claraspital AG   (Switzerland)

ⁱ UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^j UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

Boost radiotherapy; Breast conserving therapy; Fractionation; Partial breast radiotherapy; Whole breast irradiation

Indexed keywords

ANTINEOPLASTIC AGENT; IRIDIUM 192;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; EVIDENCE BASED MEDICINE; FIBROSIS; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRAOPERATIVE RADIOTHERAPY; IRRADIATION; LOW DRUG DOSE; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PARTIAL BREAST IRRADIATION; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIOISOTOPE THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GERMANY; HUMANS; MASTECTOMY, SEGMENTAL; MEDICAL ONCOLOGY; NEOPLASM INVASIVENESS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL;

EID: 84887290534     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0437-8     Document Type: Review

References (99)

1. AGO (2013) Diagnostik und Therapie primärer und metastasierter Mammakarzinome. Adjuvante Strahlentherapie. (Version 2013.1.D). http://www.ago-online.de. Arbeitsgemeinschaft Gynäkologische Onkologie
2. Agrawal RK, Alhasso A, Barrett-Lee PJ et al (2011) FAST Trialists group. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol 100(1):93-100
3. Anderson SJ, Wapnir I, Dignam JJ et al (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 27(15):2466-2473
4. Antonini N, Jones H, Horiot JC et al (2007) Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 82:265-271
5. Armaroli L, Barbieri E, Bertoni F et al (2007) Breast cancer with low risk of local recurrence: partial and accelerated radiation with three-dimensional conformal radiotherapy (3DCRT) vs. standard radiotherapy after conserving surgery (phase III study). Version 01.05.2007. http://groups.eortc. be/radio/res/irma/synopsis-trial-irma1.pdf. Accessed 27 August 2013
6. Barnett GC, Wilkinson JS, Moody AM et al (2012) Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 82(2):715-723
7. Bartelink H, Bourgier C, Elkhuizen P (2012) Has partial breast irradiation by IORT or brachytherapy been prematurely introduced into the clinic? Radiother Oncol 104:139-142
8. Bartelink H, Horiot JC, Poortmans PM et al (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25:3259-3265
9. Belkacémi Y, Fourquet A, Cutuli B et al (2011) Radiotherapy for invasive breast cancer: Guidelines for clinical practice from the French expert review board of Nice/Saint-Paul de Vence. Crit Rev Oncol Hematol 79:91-102
10. Belkacemi Y, Lartigau E, Bourgier C (2013) Standard of hypofractionated radiotherapy versus accelerated partial breast irradiation (APBI) for breast cancer (SHARE). http://www.clinicaltrials.gov/ct2/show/NCT01247233. Accessed 27 Aug 2013
11. Bentzen SM, Agrawal RK, Aird EG et al (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371:1098-1107
12. Bentzen SM, Agrawal RK, Aird EG et al (2008) The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9(4):331-341
13. Beriwal S, Schwartz GF, Komarnicky L, Garcia-Young JA (2006) Breast-conserving therapy after neoadjuvant chemotherapy. Long term results. Breast J 12:159-164
14. Biganzoli L, Wildiers H, Oakman C et al (2012) Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 13(4):148-160
15. Bonadonna G, Valagussa P, Brambilla C et al (1998) Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer institute. J Clin Oncol 16:93-100
16. Brooks JP, Danforth DN, Albert P et al (2005) Early ipsilateral breast tumor recurrences after breast conservation affect survival: An analysis of the National Cancer Institute randomized trial. Int J Radiat Oncol Biol Phys 62:785-789
17. Buchholz TA, Theriault RL, Niland JC et al (2006) The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol 24(3):361-369
18. Calais G, Berger C, Descamps P et al (1994) Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 4:1283-1288
19. Cance WG, Carey LA, Calvo BF et al (2002) Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma. Ann Surg 236:295-303
20. Chen AM, Mericc-Bernstam F, Hunt KK et al (2004) Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22:2303-2312
21. Chen AM, Meric-Bernstam F, Hunt KK et al (2005) Breast conservation after neoadjuvant chemotherapy. Cancer 103:689-695
22. Clarke M (2006) Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview. Ann Oncol 17(Suppl 10):59-62
23. Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087-2106
24. Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomized trials. Lancet 378:1707-1716
25. Dodwell DJ, Dyker K, Brown J et al (2005) A randomised study of whole-breast vs tumor-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 17:618-622
26. Donovan E, James H, Bonora M et al (2012) Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer. Med Phys 39:5814
27. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707-1716
28. Fastner G, Reitsamer R, Menzel C et al (2013) IOERT und Ganzbrustbestrahlung nach neoadjuvanter Chemotherapie beim brusterhaltend operierten Mammakarzinom. Strahlenther Onkol 189(2):176-177
29. Fastner G, Sedlmayer F, Merz F et al (2013) IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis. Radiother Oncol. doi:pii:S0167- 8140(13)00272-7. 10.1016/j.radonc.2013.05.031 (Epub ahead of print)
30. Feng M, Moran JM, Koelling T, Chughtai A et al (2011) Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 79(1):10-18
31. Fisher B, Bryant J, Wolmark N et al (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685
32. Freedman GM, Anderson PR, Goldstein LJ et al (2007) Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 68(2):347-353
33. Freedman GM, Anderson PR, Hanlon AL et al (2005) Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys 61:1328-1336
34. Gaisberger C, Steininger P, Mitterlechner B et al (2013) Three-dimensional surface scanning for accurate patient positioning and monitoring during breast cancer radiotherapy. Strahlenther Onkol (Epub ahead of print)
35. Giordano SH, Hortobagyi GN, Kau SW et al (2005) Breast cancer treatment guidelines in older women. J Clin Oncol 23(4):783-791
36. Gujral DM, Sumo G, Owen JR et al (2011) Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries. Int J Radiat Oncol Biol Phys 79:19-25
37. Hall EJ, Wuu CS (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56(1):83-88
38. Hancke K, Denkinger MD, Konig J et al (2010) Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol 21(4):748-753
39. Haviland JS, Agrawal R, Aird E et al (2012) The UK START (Standardisation of Breast Radiotherapy) Trials: 10-Year Follow-Up Results. SABCS S4-1
40. Herbert C, Nichol A, Olivotto I et al (2012) The impact of hypofractionated whole breast radiotherapy on local relapse in patients with Grade 3 early breast cancer: a population-based cohort study. Int J Radiat Oncol Biol Phys 82(5):2086-2092
41. Hughes KS, Schnaper LA, Bellon JR et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31:2382-2387
42. ICRU Report 62. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). International Commission on Radiation Units and Measurements, 1999
43. James ML, Lehman M, Hider PN et al (2010) Fraction size in radiation treatment for breast conservation in early breast cancer. Cochrane Database Syst Rev 11:CD003860
44. Jones HA, Antonini N, Hart AA et al (2009) Impact of pathological characteristics on local relapse after breast- conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol 27(30):4939-4947
45. Kirby AM, Evans PM, Helyer SJ et al (2011) A randomised trial of supine versus prone breast radiotherapy (SuPr study): comparing set-up errors and respiratory motion. Radiother Oncol 100(2):221-226
46. Leitlinienprogramm Onkologie DKG, Deutsche Krebshilfe, AWMF (2012) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. http://www.senologie.org/fileadmin/downloads/S3- Brustkrebs-v2012-OL-Langversion.pdf. Accessed 27 Aug 2013
47. Leonardi MC, Maisonneuve P, Mastropasqua MG et al (2013) Accelerated partial breast irradiation with intraoperative electrons: using GEC-ESTRO recommendations as guidance for patient selection. Radiother Oncol 106:21-27
48. Leonardi MC, Maisonneuve P, Mastropasqua MG et al (2012) How Do the ASTRO Consensus Statement Guidelines for the Application of Accelerated Partial Breast Irradiation Fit Intraoperative Radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology. Int J Radiat Oncol Biol Phys 83:806-813
49. Lin A, Moran JM, Marsh RB, Balter JM et al (2008) Evaluation of multiple breathing states using a multiple instance geometry approximation (MIGA) in inverse-planned optimization for locoregional breast treatment. Int J Radiat Oncol Biol Phys 72(2):610-616
50. Lohr F, El-Haddad M, Dobler B et al (2009) Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality. Int J Radiat Oncol Biol Phys 74:73-80
51. Mauri D, Pavlidis N, Ioannidis JP (2005) Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97(3):188-194
52. Mauriac L, MacGrogan G, Durand M et al (1999) Neoadjvuant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Ann Oncol 10:47-52
53. Min SY, Lee SJ, Shin KH et al (2011) Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 81:e697-e705
54. Moser EC, Vrieling C (2012) Accelerated partial breast irradiation: The need for well-defined patient selection criteria, improved volume definitions, close follow-up and discussion of salvage treatment. Breast 21(6):707-715
55. Nairz O, Deutschmann H, Kopp M et al (2006) A dosimetric comparison of IORT techniques in limited-stage breast cancer. Strahlenther Onkol 182:342-348
56. National Comprehensive Cancer Network (2013) NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 1.2013. http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp#site. Accessed 27 Aug 2013
57. NICE. National Institute for Clinical Excellence (NICE) (2009) Early and locally advanced breast cancer: diagnosis and treatment
58. Nielsen MH, Berg M, Pedersen AN et al (2013) Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 52:703-710
59. Njeh CF, Saunders MW, Langton CM (2010) Accelerated Partial Breast Irradiation (APBI): a review of available techniques. Radiat Oncol 5:90
60. Ontario Clinical Oncology Group, Canadian Institutes of Health Research, Canadian Breast Cancer Research Alliance. RAPID: randomized trial of accelerated partial breast irradiation. http://www.clinicaltrials.gov/ct2/show/NCT00282035. Accessed 27 August 2013
61. Orecchia R, Ciocca M, Lazzari R et al (2003) Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast 12:483-490
62. Orecchia R, Leonardi MC (2012) IORT update: what are the limits of total dose and volume? Radiother Oncol 103:SP-0097
63. Owen JR, Ashton A, Bliss JM et al (2006) Effect of radiotherapy fraction size on tumor control in patients with early-stage breast cancer after local tumor excision: long-term results of a randomised trial. Lancet Oncol 7:467-471
64. Polgár C, Fodor J, Major T et al (2007) Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast cancer: 5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69:694-702
65. Poortmans P, Aznar M, Bartelink H (2012) Quality indicators for breast cancer: revisiting historical evidence in the context of technology changes. Semin Radiat Oncol 22:29-39
66. Poortmans P (o J) Evidence based radiation oncology: breast cancer. Radiother Oncol 2007 84(1):84-101
67. Poortmans PM, Collette L, Horiot JC et al (2009) Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol 2009 90:80-85
68. Pötter R, Gnant M, Kwasny W et al., on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG) (2007) Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys 68(2):334-340
69. Prescott RJ, Kunkler IH, Williams LJ et al (2007) A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess 11(31):1-149
70. Ribeiro GG, Magee B, Swindell R et al (1993) The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol 5:278-283
71. Romestaing P, Lehingue Y, Carrie C et al (1997) Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 15:963-968
72. Rouzier M, Extra JM, Carton M et al (2001) Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol 19:3828-3835
73. RTOG (2013) A Breast cancer atlas for radiotherapy planning. Consensus definitions http://www.RTOG.org. Accessed 27 Aug 2013
74. S3 (2012) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms, Langversion 3.0, Aktualisierung 2012, AWMF-Register-Nummer: 032 - 045OL
75. Sautter-Bihl ML, Souchon R, Gerber B (2011) Adjuvant therapy for women over age 65 with breast cancer. Dtsch Arztebl Int 108(21):365-371
76. Sautter-Bihl ML, Sedlmayer F, Budach W et al (2010) Intraoperative radiotherapy as accelerated partial breast irradiation for early breast cancer: beware of one-stop shops? Strahlenther Onkol 186:651-657
77. Sautter-Bihl ML, Sedlmayer F, Budach W et al (2012) When are breast cancer patients old enough for the quitclaim of local control? Strahlenther Onkol 188(12):1069-1073
78. Sedlmayer F, Sautter-Bihl ML, Budach W et al., Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) (2013) Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO). Strahlenther Onkol 189(3):193-196
79. Smith BD, Arthur DW, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 74:987-1001
80. Smith BD, Bentzen SM, Correa CR et al (2011) Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Int J Radiat Oncol Biol Phys 81:59-68
81. Smith BD, Buchholz TA (2013) Radiation treatments after breast-conserving therapy for elderly patients. J Clin Oncol 31(19):2367-2368
82. Strnad V, Polgár C, on behalf of the European Brachytherapy Breast Cancer GEC-ESTRO Working Group (2013) Phase III multicenter trial. Interstitial brachytherapy alone versus external beam radiation therapy after breast conserving surgery for low risk invasive carcinoma and low risk duct carcinoma in-situ (DCIS) of the female breast. http://www.apbi.uni-erlangen.de. Accessed 27 August 2013
83. Swanson T, Grills IS, Ye H, Entwistle A et al (2013) Six-year experience routinely using moderate deep inspiration breath -hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer. Am J Clin Oncol 36(1):24-30
84. Tinterri C, Gatzemeier W, Zanini V et al (2009) Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomised multicentre trial. Breast 18:373-377
85. Truong PT, Bernstein V, Lesperance M et al (2006) Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg 191(6):749-755
86. Vaidya JS, Joseph DJ, Tobias JS et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomized, non-inferiority phase 3 trial. Lancet 376:91-102
87. Valachis A, Mauri D, Polyzos NP et al (2010) Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trials. Breast J 16:245-251
88. Van de Steene J, Vinh-Hung V, Cutuli B, Storme G (2004) Adjuvant radiotherapy for breast cancer: effects of longer follow-up. Radiother Oncol 72(1):35-43
89. Van de Steene J, Soete G, Storme G (2000) Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol 55(3):263-272
90. Van Der Laan HP, Hurkmans CW, Kuten A et al (2010) Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions. Radiother Oncol 94:280-285
91. Varga D, Wischnewsky M, Atassi Z, et al (2010) Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients? Oncology 78(3-4):189-195
92. Veronesi U, Orecchia R, Luini A et al (2010) Intraoperative radiotherapy during breast conserving surgery: a study on 1.822 cases treated with electrons. Breast Cancer Res Treat 124:141-151
93. Vinh-Hung V, Verschraegen C (2004) Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96(2):115-121
94. Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364(5):412-421
95. Whelan TJ, Pignol JP, Levine MN et al (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362(6):513-520
96. Wildiers H, Kunkler I, Biganzoli L et al (2007) Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol 8(12):1101-1115
97. Wolmark N, Curran WJ, Vicini F et al (2013) NSABP protocol B-39. RTOG protocol 0413. A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. http://www.rtog.org/members/protocols/0413. Accessed 27 Aug 2013
98. Yarnold J, Coles C, on behalf of the IMPORT LOW Trial Management Group (2013) Intensity modulated and partial organ radiotherapy. Randomised trial testing intensity modulated and partial organ radiotherapy following breast conservation surgery for early breast cancer. http://www.clinicaltrials. gov/ct2/show/NCT00814567. Accessed 27 Aug 2013
99. Zurl B, Stranzl H, Winkler P, Kapp KS (2010) Quantitative assessment of irradiated lung volume and lung mass in breast cancer patients treated with tangential fields in combination with deep inspiration. Strahlenther Onkol 186:157-162